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To a flask containing D-mannosamine hydrochloride (300 mg, 1.39 mmol) and N-(3dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (533 mg, 2.78 mmol) in dry DMF (5.3 mL) a solution of 1-(2-carboxyethyl)-3-methyl-1H-imidazol-3-ium chloride (400 g, 2.09 mmol) in DMF (1 mL) was added. After 10 min the reaction was cooled to 0 ºC and NEt 3 (2.8 mL, 20.0 mmol) was added. The reaction was then stirred for 24h at room temperature until the starting material was consumed. The reaction mixture was concentrated under vacuum and the crude was redissolved in DMF (7 mL) followed by the addition of pyridine (1.4 mL) and acetic anhydride (1.3 ml). The reaction mixture was stirred at room temperature for 8 h. Once the starting material was consumed, the solvents were evaporated under vacuum. The product purified by column chromatography (1 to 20% MeOH in DCM) to afford 2 as 4:3 mixture of anomers (310 mg, 46%). 1 
NMR titration experiments
NMR titrations using a model ILs 3-methyl-1-imidazol-3-ium-propionic acid 3 with Ni 2+ :NTA or 3methyl-1-imidazol-3-ium-propionate S2 with a nitriloacetic acid (NTA S3) showed that the ITags can interact with the Ni 2+ :NTA and NTA labels.
A) NMR titrations using model IL 3-methyl-1-imidazol-3-ium-propionic acid 3 with Ni 2+ :NTA in PBS
show that an interaction with the Ni 2+ :NTA labels in the presence of high salt content is possible.
However, Ni 2+ is paramagnetic and as such spectra run in the presence of Ni 2+ showed very broad signals, and although slight shifts in the spectra can be observed as the Ni 2+ :NTA is titrated in, quantification is not possible. All growth media were supplemented with antibiotic-antimycotic (Anti-Anti) and 10 % fetal bovine serum (FBS); all cell culture media and additives were purchased from Invitrogen, Life Technologies.
Confluent cultures were detached from the surface using trypsin (Tryp LE Express) and plated at 2*10 4 cells/well in either petri dishes (Mat-Tek 35 mm, with 14mm glass microwell) for imaging, or 96-well plates for other tests. All cell culture media and additives were purchased from Invitrogen, Life Technologies.
Confocal microscopy
All images were acquired on a Leica SP5 confocal system equipped with a Leica DMI 6000 inverted microscope. The images were analysed using Volocity software (PerkinElmer). NucBlue™ Live Cell Stain (Hoechst 33342) for nuclei was purchased from Life Technologies. The marker was used in line with manufacturer's protocols.
Toxicity assays
The influence of Man-ITag 2 on cell metabolism was assessed using AlamarBlue (Life Technologies), a cytosolic substrate for reductive metabolism (resazurin to resorufin) whose fluorescence spectrum changes on reduction by cytosolic enzymes. To allow for any differences in cell numbers in each well, AB fluorescence was expressed per unit protein (BCA Pierce, ThermoScientific). The metabolic competence of cells after 72 hours exposure to 2 is expressed as percentages of control ( Figure S4 ). It only the highest concetrations of 2 (1 -5mM) that caused marked decreases in metabolic competency. 
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Zeta Potential measurements
Zeta potential analyses were carried out with a Malvern Instruments Nano-Z ZEN 2600 in 0.1 M phosphate buffer. Cells were either untreated (0), or treated with 0.2 or 2 µM Ac 4 ManITag (2) for 3 days. No significant changes in zeta potential were detected (ANOVA) after treatment with 2. Increased amounts of 2 from 0.2 to 200 µM did not necessarily cause a significant increase in cell surface fluorescence (Fig. 3) .
Sialidase cell incubation.
Sialidase ( [2] S17
Cell adhesion and aggregation
Adhesion to fibronectin-coated wells Jurkat, E12, Hela (not shown) and MDA cells were exposed to concentrations of ManAc 4 -ITag 2 between 0.2 and 20 µM for 72 h, and then allowed to adhere to a fibronctin-coated plate for 2h at 37°C in RPMI supplemented with 2% FBS. After removal of supernatant and washing, cell numbers were assessed by calcein fluorescence. The expression of ITag on the surface of adherent cells and cells in solution was assessed by Calcein Am and NTA-ATTO 550 fluorescence, respectively. Figure S9 presents the number of cells that ahered to the fibronectin plate and of those that remained floating in the medium. An effect of ITag treatment was to increase, but not significantly except at 2 µM, the proportion of non-adherent cells. No significant differences in adherence to fibronectin are observed for MDA or E12 cells exposed to 20µM of 2 (figure S10 and S11), or in the NTA-ATTO fluorescence of adhering and floating cells 
Cell aggregation
Effects on cell-cell aggregation were assessed quantifying the adherence of MDA, Jurkat, HeLa and E12 cells, that had been pretreated with 2 at 20 µM to monolayers of control or treated cells, using adherence of naked wells as controls. HeLa, MDA, E12 and Jurkat which were untreated or pretreated with 2 µM ManITag 2 were plated in 96-well plates at 10 5 cells/well (for adherent cultures) or set up in 25 cm 2 T-flasks and stored for 3 days at 37 °C. Cells then allowed to adhere to monolayers of same or different cells for 2h at 37°C in RPMI supplemented with 2% FBS. After at 37°C in growth medium supplemented with 2% FBS. Cells were treated with 20 µM ManAc 4 ITag 2 (I) for 72h before the experiment, or untreated (C). Cell aggregation with the monolayer was monitored by loading them with calcein for 30 minutes prior to plating. Combinations of plated and calcein-labelled cells were explored: monolayers untreated and ITag-treated cells (IC); ITag treated monolayers and ITag treated cells (II). All results were normalized to ITag-treated cells binding to the naked wells. Figure S12 shows that ITag treatment had little or no effect on adherence of cells to confluent mononlayers of same or different cell types. 
Purification of ITag labelled glycoproteins:
Cell lysates were dyalised for 24 h at 4 °C and then freeze dried. The samples were redissolved in 500 µl of a 1:1 solution of PBS 0.02M and NaCl 1M (buffer A) and purified using a HitrapTM Q HP column.
Method A: The column was conditioned and washed with buffer A, the sample was eluted using 1:1:1 solution of PBS (0.02M), NaCl (1M), and EDTA (0.05M).
Method B: The column was loaded with ni using A solution of NiSO 4 (0.1M). After washing the column with miliQ water, the column was equilibrated and washed with buffer A. The sample was eluted using a gradient of imidazole (0.02 to 0.5 M in buffer A). The buffer of the fractions collected was then exchanged to miliQ water and aliquots of each fraction were subjected to electrophoresis on 4-12% NuPAGE gels and blotting and imaged as above. After electroblotting on polyvinylidene fluoride, the blots were incubated with SNA lectin and imaged.
Alternatively, the fractions produced after purification were incubated with mercaptoacetic acid coated QDs 3 (5 µL, 24 mg/mL) for 20 min before running the electrophoresis. Figure S13 . SNA stain purification profile (shown as a ratio to unpurified) of untreated (control) and
ITag treated MDA cells (2 µM of 2) glycoproteins eluted with different concentrations of imidazole.
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